Results 151 to 160 of about 119,898,357 (301)

LIPID PROFILE AND SERUM INSULIN LEVELS IN GESTATIONAL DIABETES

Journal of the Dow University of Health Sciences, 2008
O bjectives: To evaluate the glucose intolerance, insulin, and lipid profile in w om en who developed gestational Diabetes, compared to healthy pregnancy.
Rubina Aziz, Tabassum Mahboob
doaj  

Histamine and the mechanisms of nausea and vomiting: Translating the uncertain pharmacology of cyclizine

British Journal of Clinical Pharmacology, EarlyView.
Abstract Cyclizine is a long‐established, short‐acting drug, registered for preventing motion sickness, post‐operative nausea and vomiting (PONV) and ‘vomiting of known cause’. The latter is not defined but may include pregnancy and patients receiving palliative care, historically accepted without large, controlled trials.
Gareth J. Sanger, Paul L. R. Andrews
wiley   +1 more source

Pre- and Post-partum Levels of Serum Visfatin in Pregnant Women with Gestational Diabetes Mellitus: A Correlation

Proceedings
Introduction: Gestational diabetes mellitus is glucose intolerance diagnosed or detected for the first-time during pregnancy and has serious implications for fetal and maternal health if left untreated.
Samita Yasmin, Hifza Noor Lodhi, Faheem Mahmood, Sadia Haleema, Ghazala Rubi, Saima Qurban   +5 more
doaj   +2 more sources

Lithium‐related adverse drug reactions in children: A case–control study comparing lithium to second‐generation antipsychotics in VigiBase

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to improve the understanding of lithium's safety profile by analysing the frequency and distribution of reported adverse drug reactions (ADRs) compared to second‐generation antipsychotics (SGAs). Methods Individual case safety reports from VigiBase (1968–October 2023) involving individuals older than 2 years, with lithium or SGAs ...
Lisa T. Ringeling, Ravish N. Gangapersad, Lillian Lieuw, Patrick C. Souverein, Eibert R. Heerdink, Pilar Garcia‐Gomez, Manon H. J. Hillegers, Birgit C. P. Koch, Bram Dierckx   +8 more
wiley   +1 more source

Maternal and cord-blood inflammatory markers and BDNF in diabetic vs. non-diabetic pregnancies. [PDF]

Sci Rep
Wendel MP, Moody HL, Siegel ER, Eswaran H, Rose S.   +4 more
europepmc   +1 more source

Analysis of clinical investigation (device) initial submissions received by the Medicines and Healthcare products Regulatory Agency between January 2022 and December 2025

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse clinical investigation‐device initial submissions received by the MHRA between January 2022 and December 2025. Methods Data on submissions were extracted from the clinical investigations unit data bank; software as medical devices were not included. The predefined primary end‐point was submission type.
Andrea Manfrin, Mark Grumbridge, Daniel Hill, Crina Cacou, Graham Warren, James Pound, Jacob George, Alejandro F. Frangi   +7 more
wiley   +1 more source

Pharmacokinetics and safety of a modified‐release psilocybin formulation: A SAD Phase I trial in normal‐weight and overweight/obese participants

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to evaluate the safety, tolerability and pharmacokinetics of a novel oral modified‐release psilocybin formulation (REL‐P11) in normal‐weight and overweight/obese healthy adults and to assess its suitability for controlled, subperceptual exposure, in light of emerging evidence supporting serotonergic modulation in metabolic ...
Anna Signor, Stefano Comai, Gianfranco Pasut, Franco Folli, Marco Gentilucci, Negar Gharavi, Sofia Raitsin, Thuy Van Nguyen, Marco Pappagallo, Andrea Mattarei, Paolo L. Manfredi, Sara De Martin   +11 more
wiley   +1 more source

Attitude and awareness of dental patients towards disclosure of medical history to dentists: a cross-sectional study. [PDF]

Front Oral Health
Sembawa SN, Dustakir E, Skatawi B, Alsulayhabi N, Alghamdi M.   +4 more
europepmc   +1 more source

Complications in Pregnancy and Foetal Outcomes in Gestational Diabetes – An Observational Study in a Tertiary Hospital in Nigeria

, 2018
Background: A retrospective cohort study to compare the pregnancy complications and foetal outcomes in pregnancies complicated by  diabetes mellitus.
Benedict, Aguwa, Emmanuel, Anisiuba
core  

Prevalence of pregnancy and birth outcomes following biologic exposure in immune‐mediated inflammatory diseases: A population‐based study

British Journal of Clinical Pharmacology, EarlyView.
Aims Almost 5% of pregnancies are affected by immune‐mediated inflammatory diseases (IMIDs). As treatments become available, understanding their use during pregnancy is important. We aimed to describe maternal, pregnancy and infant outcomes among IMID pregnancies exposed to biologic therapies. Methods Using the Merative™ MarketScan® Commercial Database,
Leah K. Flatman, Lisiane F. Leal, Gabra Nohmie, Anick Bérard   +3 more
wiley   +1 more source